Pharmacokinetics Dataset in Multiple Dose Pharmacokinetic Study of Meropenem in Young Infants (<91 days) with Suspected or Complicated Intra-abdominal Infections

Timing, collection site, and results of pharmacokinetic (PK) testing, whether scavenge samples were used, records excluded from analysis, details of study drug administration, and demographics and pertinent clinical data of participants who had PK testing
Study Description
An open-label, multiple-dose study to determine the safety, tolerability, and pharmacokinetics of meropenem in preterm and term infants less than 91 days of age with suspected or confirmed intra-abdominal infections. Biospecimens are available.
Infants less than 91 days of age with suspected or confirmed intra-abdominal infection